Breast Cancer
Conference Coverage
Treating bone loss ups survival for breast cancer patients
Findings suggest a trend toward reduction in contralateral breast cancer in the treatment group.
Conference Coverage
Pembrolizumab before surgery improves survival in early triple negative breast cancer
Treatment shifts residual cancer burden to lower categories.
Conference Coverage
New treatment outperforms chemo in HER2-low breast cancer
The results may cause clinicians to reconsider how they define HER2 expression in breast cancer.
Conference Coverage
New treatment meets unmet need in breast cancer
Expert calls advance incremental, but clinically important for women with HR positive/HER2 negative breast cancer.
News
Neoadjuvant denosumab ineffective in breast cancer
Trial returns a negative result for the RANKL inhibitor, but identifies favored schedule for nab-paclitaxel.
News
‘Unlimited’ cancer costs: The Medicare Part D dilemma
Many patients with cancer who rely on Medicare Part D face an impossible choice: “Your money or your life.”
News
Time-restricted eating may reduce CVD risk after breast cancer
“You can see how that is much easier for a doctor to explain to a patient than trying to explain how to meet the physical activity guidelines each...
News
Metformin bombs in breast cancer in landmark trial
“Metformin is not effective against the most common types of breast cancer and any off-label use [of] this drug for the treatment of these common...
News
Sex hormones linked to breast cancer in men
Finding could point to a role for sex hormones, but more work needs to be done.
News
Male breast cancer risk linked with infertility
“This study helps to shed light onto a cancer type that is sadly still not very well understood, but much more research is needed to say that...